flupenthixol has been researched along with Body Weight in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adan, RA; Hillebrand, JJ; Luijendijk, MC; Verhagen, LA | 1 |
| Dobmeier, P; Kuhn, K; Scherer, J; Schmaus, W | 1 |
| Fleminger, S; Hall, MD; Jenner, P; Marsden, CD; Murugaiah, K; Theodorou, A | 1 |
| Mogil, JS; Stinus, L; Vaccarino, FJ | 1 |
| Hecht, A | 1 |
| Breen, M; Johnson, DA | 1 |
| Iversen, SD; Robbins, TW; Sahakian, BJ | 1 |
| Gottfries, CG | 1 |
3 trial(s) available for flupenthixol and Body Weight
| Article | Year |
|---|---|
[Incidence of rigor during treatment with flupentixol decanoate in comparison to risperidone].
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Basal Ganglia Diseases; Body Weight; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Flupenthixol; Haloperidol; Humans; Incidence; Male; Middle Aged; Muscle Rigidity; Neurologic Examination; Prospective Studies; Risperidone | 2004 |
Chronic dopamine antagonism facilitates opiate-induced feeding.
Topics: Animals; Body Weight; Dopamine; Dopamine Antagonists; Drug Synergism; Eating; Flupenthixol; Male; Morphine; Rats; Rats, Wistar; Weight Gain | 1995 |
Flupentixol and flupentixol decanoate, with special reference to their antipsychotic effect.
Topics: Adolescent; Adult; Aged; Body Weight; Clinical Trials as Topic; Decanoates; Flupenthixol; Humans; Injections; Mental Processes; Middle Aged; Psychotic Disorders; Schizophrenia; Thioxanthenes; Trifluoperazine | 1974 |
5 other study(ies) available for flupenthixol and Body Weight
| Article | Year |
|---|---|
Dopamine antagonism inhibits anorectic behavior in an animal model for anorexia nervosa.
Topics: Adipose Tissue; Analysis of Variance; Animals; Anorexia Nervosa; Behavior, Animal; Body Composition; Body Temperature; Body Weight; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Delivery Systems; Eating; Female; Flupenthixol; Food Deprivation; Insulin; Leptin; Motor Activity; Radioimmunoassay; Rats; Rats, Wistar | 2009 |
Alterations in different populations of striatal dopamine receptors produced by 18 months continuous administration of cis- or trans-flupenthixol to rats.
Topics: Adenylyl Cyclases; Animals; Apomorphine; Body Weight; Catalepsy; Corpus Striatum; Flupenthixol; Humans; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Stereoisomerism; Stereotyped Behavior; Thioxanthenes | 1984 |
Behavioral effects produced by long-term administration of a neuroleptic drug (flupenthixol) upon social interaction in a group of eight rats.
Topics: Animals; Apomorphine; Body Weight; Flupenthixol; Humans; Interpersonal Relations; Male; Rats; Stereotyped Behavior; Thioxanthenes; Time Factors | 1979 |
Weight changes with depot neuroleptic maintenance therapy.
Topics: Body Weight; Decanoates; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Humans; Prospective Studies; Schizophrenia; Time Factors | 1979 |
Alpha-flupenthixol-induced hyperactivity by chronic dosing in rats.
Topics: Animals; Apomorphine; Body Weight; Dextroamphetamine; Female; Flupenthixol; Humans; Motor Activity; Rats; Social Environment; Social Isolation; Stereotyped Behavior; Stimulation, Chemical; Thioxanthenes | 1976 |